- Home
- LNTH vs FRT Comparison
LNTH vs FRT Comparison
Compare LNTH & FRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LNTH
- FRT
- Stock Information
- Founded
- LNTH 1956
- FRT 1962
- Country
- LNTH United States
- FRT United States
- Employees
- LNTH N/A
- FRT N/A
- Industry
- LNTH Biotechnology: In Vitro & In Vivo Diagnostic Substances
- FRT Real Estate Investment Trusts
- Sector
- LNTH Health Care
- FRT Real Estate
- Exchange
- LNTH Nasdaq
- FRT Nasdaq
- Market Cap
- LNTH 7.5B
- FRT 8.2B
- IPO Year
- LNTH 2015
- FRT N/A
- Fundamental
- Price
- LNTH $81.74
- FRT $93.46
- Analyst Decision
- LNTH Strong Buy
- FRT Buy
- Analyst Count
- LNTH 5
- FRT 12
- Target Price
- LNTH $133.80
- FRT $117.58
- AVG Volume (30 Days)
- LNTH 1.2M
- FRT 740.8K
- Earning Date
- LNTH 05-07-2025
- FRT 05-08-2025
- Dividend Yield
- LNTH N/A
- FRT 4.71%
- EPS Growth
- LNTH N/A
- FRT 23.83
- EPS
- LNTH 3.53
- FRT 3.47
- Revenue
- LNTH $1,536,699,000.00
- FRT $1,223,443,000.00
- Revenue This Year
- LNTH $5.81
- FRT $5.09
- Revenue Next Year
- LNTH $12.26
- FRT $5.76
- P/E Ratio
- LNTH $23.18
- FRT $26.86
- Revenue Growth
- LNTH 12.53
- FRT 6.04
- 52 Week Low
- LNTH $74.34
- FRT $80.65
- 52 Week High
- LNTH $126.89
- FRT $118.34
- Technical
- Relative Strength Index (RSI)
- LNTH 29.92
- FRT 46.28
- Support Level
- LNTH $78.92
- FRT $93.52
- Resistance Level
- LNTH $108.91
- FRT $96.14
- Average True Range (ATR)
- LNTH 3.82
- FRT 1.79
- MACD
- LNTH -2.81
- FRT 0.26
- Stochastic Oscillator
- LNTH 9.40
- FRT 32.01
About LNTH Lantheus Holdings Inc.
Lantheus Holdings Inc caters to the United States healthcare sector with the development of diagnostic products. Its products are in three categories: Precision Diagnostics, Radiopharmaceutical Oncology, and Strategic Partnerships and Other Revenue. Precision Diagnostic products assist healthcare professionals Find and Follow diseases, with a focus in cardiology. Radiopharmaceutical Oncology diagnostics and therapeutics help HCPs Find, Fight and Follow cancer. Strategic Partnerships focus on enabling precision medicine through the use of biomarkers, digital solutions and pharma services platforms, and also includes license of RELISTOR to Bausch Health Companies, Inc.
About FRT Federal Realty Investment Trust
Federal Realty Investment Trust is a shopping center-focused retail real estate investment trust that owns high-quality properties in eight of the largest metropolitan markets. Its portfolio includes an interest in 102 properties, which includes 26.8 million square feet of retail space and over 3,100 multifamily units. Federal's retail portfolio includes grocery-anchored centers, superregional centers, power centers, and mixed-use urban centers. Federal Realty has focused on owning assets in highly desirable areas with significant growth, and as a result, the average population density and average median household income are higher for its portfolio than for any other retail REIT.